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A revertant was isolated from a temperature-sensitive poliovirus 2C mutant, 2C-31, which is defective in
viral RNA synthesis. This revertant, called 2C-31R1, grew well at 39°C and was not defective in RNA synthesis.
However, in contrast to its parental mutant, 2C-31R1 was cold sensitive and could hardly grow at all at 32°C.
Analysis of a single-cycle growth revealed that 2C-31R1 was defective in virion uncoating at 32°C, and a
substantial amount (more than 30%) of input viruses could be recovered as infectious particles from an infected
cell lysate up to 6 h postinfection. The uncoating defect and the inability to grow at cold temperatures could be
overcome by a brief incubation at the permissive temperature (39°C) before the infection was continued at
32°C. cDNA cloning and mix-and-match recombination experiments indicated that the defect in uncoating was
the result of two secondary point mutations, seven nucleotides apart, in the 2C-coding sequence downstream
of the inserted linker which is the original mutation in the parental 2C-31 genome. Another revertant,
2C-31R3, isolated from the same 2C-31 stock, was not defective in uncoating and appeared to be a secondary
revertant that contained an intragenic suppressor for the uncoating defect. The uncoating defect of 2C-31R1
could be complemented by type 2 poliovirus. These results suggested that protein 2C, in addition to its role in
viral RNA synthesis, has a function in determining virion structure.
Poliovirus is a single-stranded RNA virus that belongs to
the picornavirus family. The plus-sense RNA genome is
about 7.5 kilobases and encodes a single polyprotein which
is proteolytically cleaved to give rise to various structural
and nonstructural viral proteins (16, 17, 22, 23).
During poliovirus infection, the first step is the binding of
virions to specific cellular receptors found only on the
surface of certain primate cells (12, 13, 21). The virus then
enters the cell, probably through receptor-mediated endocy-
tosis, with a low pH requirement (20). At this time, the
configuration of the virion is altered drastically, and all
copies of the capsid protein VP4 are lost, making the viral
RNA genome accessible to RNase (15, 19). What triggers
this reaction is unknown, but the binding of the virion to its
cellular receptor and the subsequent changes in virion con-
figuration must play a key role. For this report, we call this
alteration reaction uncoating, recognizing that it is only the
first step toward liberating the RNA from its protein coat.
The cloning of poliovirus genome into an infectious cDNA
form (26) offered a way to study various virus-encoded
proteins that may have important functions during different
stages in the viral replication cycle (2, 3, 18). One of these
proteins is 2C, which is highly conserved among all members
of picornaviruses (1, 14, 24). Through studies of 2C mutants
made by site-directed mutagenesis, we showed previously
that 2C is involved in viral RNA synthesis (18). To further
study the function of 2C, we isolated several 2C revertants.
Surprisingly, through the study of revertant viruses derived
from one of these 2C mutants, we found that 2C may also
have a function in determining virion structure.
MATERIALS AND METHODS
Cells and viruses. HeLa cells were maintained in suspen-
sion culture in the Joklik modification of minimal essential
medium supplemented with 7.5% horse serum (GIBCO
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Laboratories, Grand Island, N.Y.). Wild-type virus and
mutant 2C-31 were isolated from single plaques (18). For
revertant isolation, about 104 PFU of 2C-31 were used to
infect each 60-mm plate of HeLa cell monolayer. After
adsorption, the plates were covered with medium containing
1% agar and incubated for 2 days at 39°C. Revertant viruses
were then isolated from single plaques under agar and plaque
purified once again before their propagation in large liquid
cultures. Type 2 poliovirus was isolated from a single plaque
from HeLa cells transfected with the plasmid pVR-204 (25),
a gift from V. Racaniello, that contains the infectious cDNA
clone of type 2 poliovirus. Both [35S]methionine and [3H]
myristic acid labeling of poliovirus-infected HeLa cells have
been described previously (11, 18). For heat or acid treat-
ment, about 108 PFU were included in 1 ml of buffer (50 mM
Tris chloride, 0.1 M NaCl, 1.5 mM MgCl2) adjusted to either
pH 7.0 or pH 5.0 and incubated at different temperatures for
periods specified in the text.
cDNA cloning and plasmid constructions. Molecular clon-
ing of revertant viruses into cDNAs was done by the method
described previously (26). After cDNA synthesis, the prep-
aration was double digested with restriction enzymes AatII
and Hindlll and an AatII-HindIII fragment from the rever-
tant cDNA encompassing the viral genomic sequence from
nucleotide 1118 to nucleotide 6056 was cloned into the
corresponding sites in the pGEM3 vector (Promega Biotec,
Madison, Wis.). Plasmid p2C-31 contains a cDNA insert
from the parental virus 2C-31, which has an EcoRI linker
insertion in the 2C-encoding sequence (18). For the con-
struction of pAH-R1, p2C-31 was double digested with AatII
and HindIII (partial) and ligated with the AatII-HindIII
cDNA fragment of 2C-31R1 described above. Further con-
structions of the plasmids for the mix-and-match analysis
were recombinations between p2C-31 and pAH-R1, except
for pSpEB-R31 (see text for the construction of pSpEB-
R31); pAE-R1, pEH-R1, and pEB-Rl contained an AatII-
EcoRI (4886), an EcoRI-HindIII, or an EcoRI-BglI (5318)
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fragment, respectively, from the 2C-31R1 cDNA, and the
rest was p2C-31 sequence.
Virus infections. About 2 x 106 to 5 x 106 HeLa cells were
collected from suspension culture and infected with various
amounts of virus in 0.2 ml. After adsorption at room tem-
perature for 30 min, fresh medium was added to each
infection and they were then incubated at various tempera-
tures for the periods specified in each experiment. At the end
of each infection, cells were collected by centrifugation and
washed once with cold medium before they were disrupted
by several cycles of freeze-and-thaw. The titer of released
virus was determined in a standard plaque assay. For study
of the uncoating defect of 2C-31R1, infected cell cultures
incubated at 32°C were divided into two parts, and at 15 min
before each time point, one part was switched to 39°C.
Virus complementation analysis. For the complementation
analysis of 2C-31R1 by type 2 poliovirus, the two stocks
were used to coinfect HeLa cells at 37°C, with a multiplicity
of infection of 10 for each virus. At 8 h postinfection (p.i.),
the culture was terminated and a virus stock was prepared
from the infected cell lysate. The virus stock was assayed at
32, 37, or 39°C to estimate the relative titer of each virus
before it was used in the subsequent uncoating analysis at
32°C (see text).
DNA sequence analysis. Sequence analysis of the revertant
cDNA clones was done by the dideoxynucleotide method of
Sanger et al. (27) with double-stranded plasmid DNA as the
template (10).
RESULTS
Isolation of cold-sensitive 2C revertant defective in uncoat-
ing. Previously, we reported the isolation of a poliovirus 2C
mutant, 2C-31, which was temperature sensitive and defec-
tive in viral RNA synthesis (18). When the virus was grown
at 39°C, revertants could be obtained at a frequency of 10-4
per replication cycle. In contrast to 2C-31, most revertants
grew well at 39°C and were not defective in viral RNA
synthesis (data not shown). One of them, named 2C-31R1,
was cold sensitive. A given stock of this virus gave 20- to
100-fold fewer plaques on HeLa cell monolayers at 32°C than
at either 37 or 39°C. In addition, plaques generated at 32°C
were much smaller than those of the wild-type virus (data
not shown). When a single cycle of growth was analyzed,
there was very little yield from 2C-31R1-infected cells even
after 7.5 h of incubation at 32°C. However, at earlier time
points, the titer of virus obtained from the infected cell
lysates was actually higher than that at later points. In fact,
the titer was several times higher than that of the wild-type
control (Fig. 1, compare the yields at 3 h p.i., for example).
Because the overall growth of 2C-31R1 was much slower
than that of the wild type as judged by the plaque size
difference of the two at 32°C, and because infectious virus
was recovered from the infected cell pellets after low-speed
centrifugation and there was less than 10% of total input
virus left in the supernatants (data not shown), it seemed
possible that 2C-31R1 had a defect in virion uncoating such
that the input virus in association with the infected cells
remained intact and infectious several hours p.i.
We tested the possibility of an uncoating defect by shifting
the infected cells at each time point during a growth curve to
the permissive temperature of 39°C for 15 minjust before the
infection was terminated. If the high numbers of infectious
particles recovered from cell lysates during the 2C-31R1
infection were due to a defect in uncoating, by shifting to the
permissive temperature, the virions should begin to uncoat
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FIG. 1. Single-cycle growth of 2C-31R1 and wild-type virus at
32°C. Each point represents virus recovered from lysates of 2.5 x
106 HeLa cells infected with either virus with a multiplicity of
infection of 10. Symbols: -, infections kept at 32°C throughout the
entire cycle; ----, infections during which temperature was shifted
from 32 to 39°C for 15 min before termination; 0, *, wild-type virus
infection; x, E, 2C-31R1 infections.
and the numbers of infectious particles recovered should be
reduced. This treatment, while it had little effect on the yield
of wild-type virus, dramatically reduced the number of
infectious particles recovered from the 2C-31R1-infected
HeLa cells up to 6 h p.i. (Fig. 1), indicating that indeed
2C-31R1 may have an uncoating defect at 32°C.
To further test this possibility, we temperature pulsed
recently infected cells by a 30-min exposure to 39°C followed
by a 7.5-h incubation at 32°C. If the inability of 2C-31R1 to
grow at 32°C was due to a defect in virion uncoating, this
brief treatment at the permissive temperature should facili-
tate the uncoating process and increase the final yield. The
temperature shift at the beginning of the infection increased
the yield of 2C-31R1 almost 20-fold, while it had little effect
on the wild-type virus (Table 1). Thus, the cold sensitivity of
2C-31R1 was very likely due to a defect during virion
uncoating.
The uncoating defect of 2C-31R1 is the result of secondary
mutations in the 2C-coding sequence. To locate the genetic
determinant(s) that caused the defect in uncoating of the
2C-31R1 virions, we partially cloned the 2C-31R1 genome by
isolating a cDNA fragment that contained the sequence from
nucleotide 1118 to nucleotide 6056. This fragment, when
recombined with the rest of the wild-type sequence and
TABLE 1. Effect of temperature shifting at the beginning
of infectiona
Virus Exptl conditions Yield (PFU/ml)
Wild type At 320C 3 x 108
Pulsed at 39°C 3.5 x 108
2C-31R1 At 320C 3 x 106
Pulsed at 39°C 5.5 x 107
a For infection 1, the temperature was kept at 32°C for the entire period of
8 h, and for infection 2, the temperature was first shifted to 39°C for 30 min and
then kept at 32°C for the rest of the incubation period.
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FIG. 2. Mix-and-match recombination analysis. Only the viral cDNA portions of the plasmid constructs are shown. The phenotypes of the
viruses derived from HeLa cells transfected with 5 ,ug of DNA from each construct are indicated at the right of the figure. Regions in boxes
represent the coding sequence of the polioviral genome. Empty boxes represent regions of the parental 2C-31 cDNA sequences, with the
arrow indicating the location of the original linker insertion (an EcoRI linker [18]) in that mutant. Solid boxes represent 2C-31R1 sequences;
the box with wavy lines represents 2C-31R3 sequence. The poliovirus genome and the relative locations of various viral proteins in the
polyprotein precursor are indicated at the top. ts, Temperature sensitive; cs, cold sensitive.
transfected into HeLa cells, gave rise to virus indistinguish-
able from 2C-31R1 (Fig. 2, see the result for plasmid pAH-
Rl). Restriction enzyme mapping indicated that the original
EcoRI linker insertion present in the parental 2C-31 genome
(18) remained intact in the 2C-31R1 cDNA, indicating that a
second-site mutation(s) was the cause of the uncoating
defect. The inserted EcoRI linker represented a unique site
in the viral genome which enabled us to locate the secondary
mutation(s) by making plasmid constructs with fragments
either upstream or downstream of the linker in a series of
mix-and-match recombinations between the 2C-31 and 2C-
31R1 sequences. As shown in Fig. 2, for pEB-Rl, introduc-
tion of an EcoRI (4886)-BglI (5318) fragment of the 2C-31R1
cDNA containing 432 base pairs downstream from the linker
into the 2C-31 genome gave rise to virus that was cold
sensitive and was also shown to be defective in virion
uncoating at 32°C (data not shown). The segment upstream
of the Rl site gave rise to temperature-sensitive virus and
therefore had no suppression activity (pAE-R1 in Fig. 2).
Direct DNA sequence analysis of the EcoRI-BgIl fragment
revealed only two point mutations at nucleotides 5000 and
5007 that both resulted in conservative amino acid residue
changes in the 2C polypeptide sequence (Fig. 3). These
changes appeared to be responsible both for the reversion of
2C-31 mutation and for causing the uncoating defect.
The uncoating defect could be suppressed by additional
mutation in 2C sequence. Another revertant, 2C-31R3, iso-
lated from the same virus stock from which 2C-31R1 was
obtained was not cold sensitive and uncoated well at 32°C
(data not shown). When its cDNA sequence was analyzed, it
was found that it contained the sequence identical to that of
2C-31R1 downstream of the EcoRI linker site and could
confer the same cold-sensitive-uncoating defect phenotype
when recombined with the rest of 2C-31 sequence (data not
shown). Apparently, it contained a sequence(s) elsewhere
that could suppress the determinant of the uncoating defect.
Indeed, when an SphI (4154)-EcoRI (4886) cDNA fragment
of 2C-31R3 was recombined with the EcoRI-BglI fragment
from 2C-31R1 cDNA, the cold-sensitive phenotype was
suppressed and the virus obtained had the same phenotype
as that of 2C-31R3 (Fig. 2, see the result of pSpEB-R31).
DNA sequence analysis indicated that a single point muta-
tion at nucleotide 4542 of the 2C-coding sequence resulting
in an asparagine-to-serine residue change (Fig. 3) was suffi-
cient to revert the uncoating defect caused by mutations in
the 2C-31R1 genome.
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EcoRI Insert
VPg |1AB2 3AB 30 3D3,1 (A)n
EcoRI insert
4542 5000 5007
2C-31
--AAC--(346NT)--[GGAATTCCI--(1 14NT)--ATGGACAAA-
-Asn- -Met-Asp-Lys-
4542 5000 5007
2C-31R1
--AAC--(346NT)--[GGAATTCC]--(114NT)--GTGGACAGA-
-Asn- -Val-Asp-Arg-
4542 5000 5007
2C-31R3
--AGC--(346NT)--[GGAATTCC].-(114NT)--GTGGACAGA-
-Ser-
-Val-Asp-Arg-
FIG. 3. Secondary mutations found in the revertant genomes. The arrow indicates the location of an EcoRI linker insertion in the parental
2C-31 genome. Numbers above the sequence indicate the locations of secondary point mutations found in either 2C-31R1 or 2C-31R3 cDNA,
and the resulting amino acid residue changes are underlined.
Complementation of 2C-31R1 by type 2 poliovirus. To
determine whether the uncoating defect of 2C-31R1 could be
complemented by another poliovirus, we coinfected HeLa
cells with 2C-31R1 and poliovirus type 2 under conditions
permissive for both viruses and then harvested the virus
from the coinfection and analyzed the uncoating of the virus
in a subsequent infection done at 32°C. We reasoned that if
the uncoating defect of 2C-31R1 could be corrected by the
presence of type 2 poliovirus during the first round of
infection, then there should be no significant amount of
2C-31R1 blocked at the uncoating stage during the subse-
quent infection at 32°C. On the other hand, if the defect
resided in the RNA and not in the 2C protein and therefore
could not be complemented, or if the defect had a dominant
negative effect, then there should be a large amount of either
2C-31R1 alone or 2C-31R1 and type 2 blocked at uncoating.
We chose type 2 poliovirus as the partner for the following
reasons. First, it grows at about the same rate as 2C-31R1 at
37°C, a temperature that is relatively permissive for both
viruses and at which the first round of coinfection could be
carried out. This is important because the ideal helper virus
should replicate well during coinfection to provide enough
2C protein but not well enough to outgrow 2C-31R1. Second,
type 2 poliovirus has a partial temperature sensitivity such
that at 39°C it forms a reduced number of plaques with a
distinctive small-plaque morphology. Incubation at different
temperatures thus provided a convenient way to distinguish
the progeny carrying the type 2 genome from that with
2C-31R1 in the mixed virus stock harvested from the coin-
fection (see below). Third, type 2 recombines poorly with
type 1, minimizing the confounding effects of recombination.
When equal numbers of type 2 and 2C-31R1 were used to
coinfect HeLa cells, the virus harvested from the culture 7 h
p.i. at 37°C contained about 60% 2C-31R1 and 40% type 2
poliovirus. This calculation was based on the observation
that both the cold-sensitive 2C-31R1 and the temperature-
sensitive type 2 poliovirus had a titer reduction of more than
20-fold when assayed at either 32 or 39°C, respectively
(Table 2, lines 1 and 2). Therefore, in the mixed yield from
coinfection, the titer at 39°C will represent mainly 2C-31R1
and the titer at 32°C will represent mainly type 2 poliovirus.
The mixed yield had 2.3 x 108 PFU at 320C (type 2) and 4 x
108 PFU at 390C (2C-31R1). This was confirmed by noting
that in the assay for the mixed virus, almost all plaques
formed at 320C had a morphology similar to that of type 2
virus, while all plaques formed at 39°C were similar to those
of 2C-31R1 (data not shown).
When this virus stock was used in the second round of
infection carried out at 32°C, only about 2 to 3% of the total
input virus could be recovered as infectious particles from
the cell lysate 3 h p.i., a value similar to that observed for
type 2 or the wild-type (type 1) virus (Fig. 1), while over 30%
of the total input virus could be recovered from cells infected
with 2C-31R1 alone (Table 3). This clearly indicated that the
TABLE 2. Yield of virus from single-cycle infections at 37oCa
Titer (PFU/ml) at:
Virus
320C 37°C 390C
2C-31R1 2 x 107 5 x 108 5 x 108
Type 2 4 x 108 2.2 x 108 1 X 107
2C-31R1 + type 2 2.3 x 108 5 x 108 4 x 108
a Titers of viruses recovered from lysates of 2 x 106 HeLa cells were
determined by the standard plaque assay at different temperatures.
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TABLE 3. Complementation of 2C-31R1 by type 2 poliovirusa
Titer (PFU/ml)b at:
Virus
32°C 39°C
2C-31R1 8.6 x 106 (8.2 x 105)
Type 2 8 x 105 (1.8 x 105)
2C-31R1 + type 2 2 x 105 (2 x 104) 6 x 105 (6 x 104)
a About 5 x 106 HeLa cells were infected with each virus preparation
(Table 2), with a multiplicity of infection of 10.
b Numbers represent virus recovered from one-half of the culture that was
kept either at 32°C or shifted to 39°C for 15 min (in parentheses) before
terminating the infection.
2C-31R1 progeny from the coinfection with type 2 poliovirus
were able to uncoat in the subsequent infection at 32°C.
Therefore, the genetic determinant of the uncoating defect
could be complemented and did not reside in the RNA of
2C-31R1 but rather in the 2C protein itself.
The capsid proteins of 2C-31R1 are properly processed and
myristoylated. When the 2C-31R1 virions were labeled with
[35S]methionine, the cleavage pattern of various virion pro-
teins appeared normal on sodium dodecyl sulfate-polyacryl-
amide gels (Fig. 4A). It is known that poliovirus capsid
protein VP4 and its precursor, VPO, are myristoylated (11).
The same modification was found for the 2C-31R1 capsid
(Fig. 4B).
Physical properties of 2C-31R1 virions. Poliovirus virions
are relatively heat stable and resistant to mild acid treat-
ment. When the purified 2C-31R1 virions were subjected to
mild heat (43°C, 15 min) or acid (pH 5, 1 h) treatment, they
showed a degree of resistance similar to that of the wild type
(Table 4).
DISCUSSION
The previously described poliovirus mutant 2C-31 is de-
fective in viral RNA synthesis (18). It is surprising, there-
fore, that revertant 2C-31R1 became defective in virion
uncoating. 2C-31R1 contained secondary mutations in the
A
TABLE 4. Physical properties of 2C-31R1 virions'
Titer (PFU/ml)
Virus Temp pH
22°C 43°C 7.0 5.0
Wild type 6.5 x 107 1.5 X 107 6.0 x 107 6.6 x 107
2C-31R1 1.0 x 108 3.6 x 107 9.6 x 107 6.6 x 107
" About 108 virions were kept either at different temperatures for 15 min or
at a different pH for 1 h. The titer was then determined by a standard plaque
assay.
2C-coding sequence that resulted in two conservative amino
acid residue changes in the polypeptide sequence down-
stream of the original mutation. These changes in the 2C
sequence apparently resulted in the defect in virion uncoat-
ing. Because protein 2C was not found in the virions and
because the defect of uncoating could be complemented, the
results imply that protein 2C, in addition to its function in
viral RNA synthesis, plays a role in determining virion
structure. How 2C might be involved in this process is not
clear.
Previous data suggested that protein 2C is tightly associ-
ated with the membrane-bound viral replication complex in
poliovirus-infected cells (4, 5, 29) and that it may be involved
in the initiation of viral RNA synthesis (8, 9, 18, 30). Because
only the newly made viral RNAs are incorporated into
virions (6), it has been postulated that viral RNA replication
and virion formation are coupled processes which occur in
association with membranes (6, 7). One of the functions of
2C, therefore, could be to facilitate virion assembly around
newly made viral RNA. This could be either to help the
virion building blocks to recognize the potential packaging
signal associated with the viral RNA or to provide a proper
environment for the virion assembly. It was found that the
assembly of the 14S subunits into 74S empty capsids in vitro
could be facilitated by membrane fractions isolated from
poliovirus-infected cells (23), a finding which has been
interpreted as supporting the hypothesis that there is a
membrane-associated virus-specific assembly factor.
B
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FIG. 4. Cleavage and myristoylation of the capsid proteins. (A) [35S]methionine-labeled virions were purified from a 10 to 30% sucrose
gradient and analyzed by electrophoresis through a 12.5% sodium dodecyl sulfate-polyacrylamide gel. Lane 1, Wild type; lane 2, 2C-31R1.
(B) Lysates of [3H]myristic acid-labeled HeLa cells that were infected with either wild-type (lane 2) or 2C-31R1 (lane 3) virus were analyzed
through a similar gel as in panel A. [35S]methionine-labeled wild-type virions (lane 4) or infected cell lysate (lane 1) were included as controls.
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Alternatively, 2C may provide some modification(s) for
the capsid proteins that may be required for the maturation
of the virions. The only known modification of the picorna-
viral capsid is the myristoylation of VP4 and its precursor,
VPO (11). While the role of this myristoylation in either
virion assembly or uncoating is unknown, the same myris-
toylation pattern was found for the 2C-31R1 capsids (Fig.
4B) and therefore a defect in myristoylation does not appear
to account for the uncoating defect of 2C-31R1 virions.
The nature of the uncoating defect of the 2C-31R1 virions
is not clear. Because almost all the virus became tightly
associated with cells within the first hour of infection and
there was little virus left in the culture medium that could be
recovered as infectious particles (data not shown), the
potential alteration(s) that affects virion uncoating appar-
ently does not affect the binding of virions to the cellular
receptors. Poliovirions are known to be relatively heat stable
and resistant to mild acidity, and the 2C-31R1 virions appear
to have retained these properties (Table 4).
It is not clear whether the reversion of the temperature-
sensitive phenotype was caused by one or both of the
secondary point mutations found in the 2C-31R1 genome or
how these mutations contribute to the uncoating defect.
Site-directed mutagenesis with synthetic oligonucleotides
containing one or both mutations is under way to address
these questions.
Although 2C-31R3 was isolated from the same parental
2C-31 stock from which 2C-31R1 was obtained, it is likely
that 2C-31R3 is a secondary revertant derived from 2C-31R1.
The 2C-31 stock had been through a few passages at 32°C,
which might have facilitated the generation of secondary
revertants from 2C-31R1.
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